Cantor Fitzgerald Initiates Coverage On Madrigal Pharmaceuticals with Neutral Rating
Madrigal Pharmaceuticals, Inc. +3.00% Pre
Madrigal Pharmaceuticals, Inc. MDGL | 217.00 217.00 | +3.00% 0.00% Pre |
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Madrigal Pharmaceuticals (NASDAQ:
MDGL) with a Neutral rating.